Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2006 7
2007 7
2008 2
2009 9
2010 11
2011 7
2012 6
2013 7
2014 4
2015 9
2016 9
2017 9
2018 10
2019 9
2020 10
2021 12
2022 6
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Idelalisib.
Zirlik K, Veelken H. Zirlik K, et al. Among authors: veelken h. Recent Results Cancer Res. 2018;212:243-264. doi: 10.1007/978-3-319-91439-8_12. Recent Results Cancer Res. 2018. PMID: 30069634 Review.
Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing.
Arindrarto W, Borràs DM, de Groen RAL, van den Berg RR, Locher IJ, van Diessen SAME, van der Holst R, van der Meijden ED, Honders MW, de Leeuw RH, Verlaat W, Jedema I, Kroes WGM, Knijnenburg J, van Wezel T, Vermaat JSP, Valk PJM, Janssen B, de Knijff P, van Bergen CAM, van den Akker EB, Hoen PAC', Kiełbasa SM, Laros JFJ, Griffioen M, Veelken H. Arindrarto W, et al. Among authors: veelken h. Leukemia. 2021 Jan;35(1):47-61. doi: 10.1038/s41375-020-0762-8. Epub 2020 Mar 3. Leukemia. 2021. PMID: 32127641 Free PMC article.
Energy overpowers sweet tooth in FL.
Veelken H. Veelken H. Blood. 2023 Dec 28;142(26):2226-2229. doi: 10.1182/blood.2023022268. Blood. 2023. PMID: 38153769 No abstract available.
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Chamuleau MED, Stenner F, Chitu DA, Novak U, Minnema MC, Geerts P, Stevens WBC, Zenz T, van Imhoff GW, Wu KL, Demandt AMP, Kersten MJ, Terpstra WE, Tick LW, Deeren D, Van Den Neste E, Gregor M, Veelken H, Böhmer LH, Caspar CB, Mutsaers P, Refos JM, Sewsaran R, Fu L, Seefat RL, Uyl-de Groot CA, Dirnhofer S, Van Den Brand M, de Jong D, Nijland M, Lugtenburg P. Chamuleau MED, et al. Among authors: veelken h. Lancet Haematol. 2023 Dec;10(12):e966-e975. doi: 10.1016/S2352-3026(23)00279-X. Epub 2023 Oct 31. Lancet Haematol. 2023. PMID: 37922925 Clinical Trial.
Tandem Substitutions in Somatic Hypermutation.
Sepúlveda-Yáñez JH, Alvarez Saravia D, Pilzecker B, van Schouwenburg PA, van den Burg M, Veelken H, Navarrete MA, Jacobs H, Koning MT. Sepúlveda-Yáñez JH, et al. Among authors: veelken h. Front Immunol. 2022 Jan 7;12:807015. doi: 10.3389/fimmu.2021.807015. eCollection 2021. Front Immunol. 2022. PMID: 35069591 Free PMC article.
Legionellosis after hematopoietic stem cell transplantation.
Mikulska M, Tridello G, Hoek J, Gil L, Yañez L, Labussière-Wallet H, Passweg J, Xhaard A, Pioltelli P, Caillot D, Michel G, Veelken H, Blaise D, Bruno B, Garcia CB, Itälä-Remes M, Crawley C, Bourhis JH, Kaare A, Arcese W, Parody R, Styczynski J. Mikulska M, et al. Among authors: veelken h. Bone Marrow Transplant. 2021 Oct;56(10):2555-2566. doi: 10.1038/s41409-021-01333-7. Epub 2021 May 22. Bone Marrow Transplant. 2021. PMID: 34023859
Active immunotherapy in follicular lymphoma.
Veelken H. Veelken H. Semin Cancer Biol. 2003 Jun;13(3):241-7. doi: 10.1016/s1044-579x(03)00020-8. Semin Cancer Biol. 2003. PMID: 12959355 Review.
COVID-19 and systemic anticancer therapy: exploiting uncertainty.
Gelderblom H, Veelken H, Stiggelbout AM. Gelderblom H, et al. Among authors: veelken h. Lancet Oncol. 2021 Jan;22(1):3-5. doi: 10.1016/S1470-2045(20)30700-2. Epub 2020 Nov 27. Lancet Oncol. 2021. PMID: 33253642 Free PMC article. No abstract available.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
van der Straten L, Stege CAM, Kersting S, Nasserinejad K, Dubois J, Dobber JA, Mellink CHM, van der Kevie-Kersemaekers AF, Evers LM, de Boer F, Koene HR, Schreurs J, van der Klift M, Velders GA, van der Spek E, van der Straaten HM, Hoogendoorn M, van Gelder M, Posthuma EFM, Visser HPJ, Houtenbos I, Idink CAM, Issa DE, Dompeling EC, van Zaanen HCT, Veelken JH, Levenga H, Tick LW, Terpstra WE, Tonino SH, Westerweel PE, Langerak AW, Kater AP, Levin MD. van der Straten L, et al. Among authors: veelken jh. Blood. 2023 Sep 28;142(13):1131-1142. doi: 10.1182/blood.2023020195. Blood. 2023. PMID: 37363833
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL.
Eken JA, Koning MT, Kupcova K, Sepúlveda Yáñez JH, de Groen RAL, Quinten E, Janssen J, van Bergen CAM, Vermaat JSP, Cleven A, Navarrete MA, Ylstra B, de Jong D, Havranek O, Jumaa H, Veelken H. Eken JA, et al. Among authors: veelken h. J Exp Med. 2024 May 6;221(5):e20230941. doi: 10.1084/jem.20230941. Epub 2024 Mar 21. J Exp Med. 2024. PMID: 38512136 Free PMC article.
128 results